Company intelligence / Profile preview

Cunzhen Qiushi

Shenzhen, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Cunzhen Qiushi (Shenlanbao) operates insurance knowledge-based content and insurance product reviews, and has expanded into digital clinical trial recruitment and multichannel marketing for pharmaceutical and biotech companies. Its E-Find Platform has shown strong performance, enrolling over 800 patients and onboarding 90 new clinical trial programs in a single quarter, serving 135 pharmaceutical companies and CROs in the third quarter of 2023. Waterdrop acquired a controlling (60%) interest in Cunzhen Qiushi in July 2023, and it is now consolidated into Waterdrop’s financial statements.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Multiple global pharmaceutical companiesContract research organizations (CROs)[5]

Beyond the preview

Go deeper on Cunzhen Qiushi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cunzhen Qiushi.

Explore the full profile